Cardiovascular safety of non-aspirin non-steroidal anti-inflammatory drugs: review and position paper by the working group for Cardiovascular Pharmacotherapy of the European Society of Cardiology

被引：35

作者：

Schmidt, Morten ^{[1
]}

Lamberts, Morten ^{[2
]}

Olsen, Anne-Marie Schjerning ^{[2
]}

Fosboll, Emil ^{[3
]}

Niessner, Alexander ^{[4
]}

Tamargo, Juan ^{[5
]}

Rosano, Giuseppe ^{[6
,7
]}

Agewall, Stefan ^{[8
,9
]}

Kaski, Juan Carlos ^{[10
]}

Kjeldsen, Keld ^{[11
,12
,13
]}

Lewis, Basil S. ^{[14
]}

Torp-Pedersen, Christian ^{[15
]}

机构：

[1] Aarhus Univ Hosp, Dept Clin Epidemiol, Olof Palmes Alle 43-45, DK-8200 Aarhus, Denmark

[2] Copenhagen Univ Hosp Gentofte, Dept Cardiol, Hellerup, Denmark

[3] Rigshosp, Copenhagen Univ Hosp, Ctr Heart, Dept Cardiol, Copenhagen, Denmark

[4] Med Univ Vienna, Div Cardiol, Dept Internal Med 2, Vienna, Austria

[5] Univ Complutense, Sch Med, Dept Pharmacol, E-28040 Madrid, Spain

[6] IRCCS San Raffaele Roma, Rome, Italy

[7] St George Hosp, Cardiovasc & Cell Sci Inst, London, England

[8] Oslo Univ Hosp Ulleval, Dept Cardiol, Oslo, Norway

[9] Univ Oslo, Inst Clin Med, Oslo, Norway

[10] St Georges Univ London, Div Cardiac & Vasc Sci, London, England

[11] Rigshosp, Copenhagen Univ Hosp, Copenhagen, Denmark

[12] Holbaek Cent Hosp, Holbaek, Denmark

[13] Aalborg Univ, Fac Med, Aalborg, Denmark

[14] Technion Israel Inst Technol, Ruth & Bruce Rappaport Sch Med, Lady Davis Carmel Med Ctr, Tel Aviv, Israel

[15] Aalborg Univ, Dept Hlth Sci & Technol, Aalborg, Denmark

来源：

EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY | 2016年 / 2卷 / 02期

关键词：

RECEIVING ANTITHROMBOTIC THERAPY; CYCLOOXYGENASE-2; INHIBITORS; MYOCARDIAL-INFARCTION; SELECTIVE INHIBITORS; ATRIAL-FIBRILLATION; DOUBLE-BLIND; RISK; METAANALYSIS; CELECOXIB; ASPIRIN;

D O I：

10.1093/ehjcvp/pvv054

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：108 / 118

页数：11

共 86 条

[1] Expert position paper on the use of proton pump inhibitors in patients with cardiovascular disease and antithrombotic therapy [J].

Agewall, Stefan ;

Cattaneo, M. ;

Collet, J. P. ;

Andreotti, F. ;

Lip, G. Y. H. ;

Verheugt, F. W. A. ;

Huber, K. ;

Grove, E. L. ;

Morais, J. ;

Husted, S. ;

Wassmann, S. ;

Rosano, G. ;

Atar, D. ;

Pathak, A. ;

Kjeldsen, K. ;

Storey, R. F. .

EUROPEAN HEART JOURNAL, 2013, 34 (23) :1708-+

[2]

Aldington Sarah, 2005, N Z Med J, V118, pU1755

[3]

[Anonymous], 2015, FDA DRUG SAF COMM FD

[4] Use of nonsteroidal Antiinflammatory drugs an update for clinicians - A scientific statement from the American Heart Association [J].

Antman, Elliott M. ;

Bennett, Joel S. ;

Daugherty, Alan ;

Furberg, Curt ;

Roberts, Harold ;

Taubert, Kathryn A. .

CIRCULATION, 2007, 115 (12) :1634-1642

[5] Meta-analysis of cyclooxygenase-2 inhibitors and their effects on blood pressure [J].

Aw, TJ ;

Haas, SJ ;

Liew, D ;

Krum, H .

ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (05) :490-496

[6] Cyclooxygenase-2 inhibitors and cardiovascular risk in a nation-wide cohort study after the withdrawal of rofecoxib [J].

Back, Magnus ;

Yin, Li ;

Ingelsson, Erik .

EUROPEAN HEART JOURNAL, 2012, 33 (15) :1928-1933

[7]

Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71

[8]

Bainbridge D, 2006, CAN J ANAESTH, V53, P46, DOI 10.1007/BF03021527

[9] Cardiovascular events associated with rofecoxib: final analysis of the APPROVe trial [J].

Baron, John A. ;

Sandler, Robert S. ;

Bresalier, Robert S. ;

Lanas, Angel ;

Morton, Dion G. ;

Riddell, Robert ;

Iverson, Erik R. ;

DeMets, David L. .

LANCET, 2008, 372 (9651) :1756-1764

[10] A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas [J].

Baron, John A. ;

Sandler, Robert S. ;

Bresalier, Robert S. ;

Quan, Hui ;

Riddell, Robert ;

Lanas, Angel ;

Bolognese, James A. ;

Oxenius, Bettina ;

Horgan, Kevin ;

Loftus, Susan ;

Morton, Dion G. .

GASTROENTEROLOGY, 2006, 131 (06) :1674-1682

← 1 2 3 4 5 6 7 8 9 →